Ann: R327 Efficacy against WHO Priority Pathogen Acinetobacter B, page-7

There has been zero explanation about why they couldn't recruit for the Burns or the DFI trials. On the contrary, they continue to refer to the burns trial as "successful" or "complete", rather than the actual: "stopped early due to participant recruitment difficulties".

And the problem with those random photos of patients is that they are not science. They are purely designed to impress naive retail investors, thinking that they are meaningful. They are not controlled, we have no idea if RCE pixie juice was responsible for any improvement, or how the product was used, what other therapies the patient was taking, how much placebo was involved, how many patients accessed under the scheme that we didn't hear about.

If the product is so effective, why do they struggle to recruit their trials?